Dr. Robin Jones on Olaratumab and Doxorubicin in Patients with Soft Tissue Sarcoma
3 Görünümler
• 07/18/23
0
0
gömmek
administrator
Aboneler
Robin Jones, BSc, MB, MRCP, MD, oncologist, Royal Marsden Hospital, London, discusses the effectiveness of monoclonal antibody olaratumab in combination with doxorubicin in unresectable and metastatic soft tissue sarcoma.
For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
Daha fazla göster
Facebook Yorumları
SORT BY-
En Çok Yorumlananlar
-
Son Yorumlar